A Long Term Study of SPP100 in Patients With Essential Hypertension (Trial is Not Recruiting in the US)

Safety and Efficacy Study of LHW090 in Resistant Hypertension Patients

NCT02515331 ·Status: COMPLETED ·Phase: PHASE2

Open-Label Extension Study of Patients Previously Enrolled in Study CIN-107-124

NCT05459688 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of SPA100 (Fixed-dose Combination of Aliskiren/Amlodipine) in Patients With Essential Hypertension

NCT01237223 ·Status: COMPLETED ·Phase: PHASE3

A Study of CIN-107 in Adults With Treatment-Resistant Hypertension (rHTN)

NCT04519658 ·Status: COMPLETED ·Phase: PHASE2

Pharmacokinetic and Pharmacodynamic Profiles of Aliskiren in Japanese Patients With Mild to Moderate Essential Hypertension

NCT00424541 ·Status: COMPLETED ·Phase: PHASE1

A Study Of Different Doses Of TBC3711 In Patients With Uncontrolled High Blood Pressure Already Taking Medications For High Blood Pressure.

NCT00272961 ·Status: TERMINATED ·Phase: PHASE2

Study Comparing SPP100 (Aliskiren) 150mg to Placebo and to Losartan 50mg in Patients With Mild to Moderate Essential Hypertension

NCT00344110 ·Status: COMPLETED ·Phase: PHASE3

Pharmacovigilance and Patient Compliance in Hypertensive Patients

NCT02200575 ·Status: COMPLETED

Study to Evaluate the Efficacy and Safety of SPH3127 In Patients With Mild-moderate Essential Hypertension

NCT05359068 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate CIN-107 for the Treatment of Patients With Uncontrolled Hypertension and Chronic Kidney Disease

NCT05432167 ·Status: COMPLETED ·Phase: PHASE2

An Efficacy, Safety, Tolerability and Dose Finding Study of XXB750 in Resistant Hypertension Patients.

NCT05562934 ·Status: COMPLETED ·Phase: PHASE2

Optimum Treatment for Drug-Resistant Hypertension

NCT02369081 ·Status: UNKNOWN ·Phase: PHASE4

A Study Of Valsartan Used To Treat Hypertension For Up To 13 Months In Hypertensive Children Ages 6 - 16 Years Of Age

NCT00171041 ·Status: COMPLETED ·Phase: PHASE3

A Clinical Study to Compare Long-term Efficacy and Safety of an Aliskiren Based Regimen to a Hydrochlorothiazidebased Treatment Regimen With Optional Addition of Amlodipine

NCT00219154 ·Status: COMPLETED ·Phase: PHASE3

A Study to Identify an Optimal Dose of QCZ484 in Mild to Moderate Hypertensive Patients

NCT06857955 ·Status: RECRUITING ·Phase: PHASE2

Study Describing the Hypertensive Population Treated With Telmisartan and Conditions of Use by Medical Practitioners and Patients

NCT02242851 ·Status: COMPLETED

Efficacy and Safety of Valsartan Plus Hydrochlorothiazide in Fixed Dose Combination in Hypertensive Patients Not Controlled by the Free Combination of an Angiotensin Receptor Blocker Plus Hydrochlorothiazide

NCT00360178 ·Status: COMPLETED ·Phase: PHASE3

Trial on the Safety and Efficacy of MLS-101 in Patients With Uncontrolled Hypertension

NCT05001945 ·Status: COMPLETED ·Phase: PHASE2

A Study Comparing Valsartan With And Without Hydrochlorothiazide In Patients With Hypertension

NCT00241007 ·Status: COMPLETED ·Phase: PHASE3

A Research Study to Show the Effect of Aprocitentan in the Treatment of Difficult to Control (Resistant) High Blood Pressure (Hypertension) and Find Out More About Its Safety

NCT03541174 ·Status: COMPLETED ·Phase: PHASE3

A Clinical Study to Assess Efficacy and Safety of Aliskiren in the Elderly With High Blood Pressure

NCT00219167 ·Status: COMPLETED ·Phase: PHASE3

Effects of Intensive Systolic Blood Pressure Lowering Treatment in Reducing RIsk of Vascular evenTs (ESPRIT) Study

NCT04030234 ·Status: COMPLETED ·Phase: NA

Efficacy and Safety of LCZ696A in Patients With Essential Hypertension

NCT00549770 ·Status: COMPLETED ·Phase: PHASE2

Hypertension and Cardiovascular Risk Factors

NCT00171782 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety of Valsartan and Amlodipine (± HCTZ) in Adults With Moderate, Inadequately Controlled Hypertension

NCT00523744 ·Status: COMPLETED ·Phase: PHASE3